DAFNA Capital Management LLC - BOLT BIOTHERAPEUTICS INC ownership

BOLT BIOTHERAPEUTICS INC's ticker is BOLT and the CUSIP is 097702104. A total of 63 filers reported holding BOLT BIOTHERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
DAFNA Capital Management LLC ownership history of BOLT BIOTHERAPEUTICS INC
ValueSharesWeighting
Q4 2021$490,000
-61.3%
100,0000.0%0.12%
-63.4%
Q3 2021$1,265,000
-18.2%
100,0000.0%0.34%
+4.0%
Q2 2021$1,546,000100,0000.32%
Other shareholders
BOLT BIOTHERAPEUTICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
Pivotal bioVenture Partners Investment Advisor LLC 1,891,467$1,418,6001.09%
Nan Fung Group Holdings Ltd 1,166,952$875,2140.93%
TANG CAPITAL MANAGEMENT LLC 3,812,773$2,859,5800.29%
Acuitas Investments, LLC 630,507$472,8800.25%
Vivo Capital, LLC 3,521,291$2,640,9680.24%
Newtyn Management, LLC 1,363,234$1,022,4250.19%
Samsara BioCapital, LLC 1,049,153$786,8650.16%
Sofinnova Investments, Inc. 2,754,437$2,065,8280.11%
Board of Trustees of The Leland Stanford Junior University 719,546$539,6590.04%
ADAR1 Capital Management, LLC 185,999$139,4990.03%
View complete list of BOLT BIOTHERAPEUTICS INC shareholders